• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗜酸粒细胞性食管炎的成本效益护理。

Cost-effective care in eosinophilic esophagitis.

机构信息

Center for Esophageal Diseases and Swallowing, and Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, NC.

出版信息

Ann Allergy Asthma Immunol. 2019 Aug;123(2):166-172. doi: 10.1016/j.anai.2019.04.010. Epub 2019 Apr 19.

DOI:10.1016/j.anai.2019.04.010
PMID:31009702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6679981/
Abstract

OBJECTIVE

To examine costs related to eosinophilic esophagitis (EoE), understand the source of these costs, discuss a possible approach for cost-effective care in EoE, and identify areas for future research in this topic.

DATA SOURCES/STUDY SELECTIONS: Narrative review of the literature from 1977 (first description of EoE) to March 2019, focusing on costs and cost-effectiveness analyses in EoE.

RESULTS

High costs in EoE can be related to diagnostic delays, requirement for upper endoscopy with biopsy for diagnosis and monitoring of disease activity, expensive medications currently used off-label, increased food costs related to dietary elimination treatment, frequent doctor visits with subspecialists, and complications or disease exacerbations. Provision of cost-effective care in EoE is an understudied area, and a patient-centric approach is key. There are multiple areas in which future research can make an impact. These include determining predictors of treatment response, minimally or noninvasive methods to monitor disease activity, and validation of the use of multidisciplinary care.

CONCLUSION

Eosinophilic esophagitis (EoE) is considered to be a rare disease, but the costs of care and burden of disease attributed to EoE are substantial. However, few studies examine either the costs related to EoE or the approach to cost-effective care for the EoE patient. To provide cost-effective care, a patient-centric approach and shared decision-making model are optimal. In addition, a rational strategy for EoE diagnosis and initial treatment, effective maintenance therapy for disease control and ideally to prevent complications, and appropriate long-term monitoring are all required.

摘要

目的

探讨嗜酸性粒细胞性食管炎(EoE)相关的成本,了解这些成本的来源,讨论 EoE 成本效益护理的可能方法,并确定该主题未来研究的方向。

资料来源/研究选择:对 1977 年(首次描述 EoE)至 2019 年 3 月的文献进行叙述性综述,重点关注 EoE 的成本和成本效益分析。

结果

EoE 中的高成本可能与诊断延误、诊断和监测疾病活动需要进行上消化道内镜检查和活检、目前标签外使用的昂贵药物、与饮食消除治疗相关的增加的食物成本、经常就诊于专科医生以及并发症或疾病恶化有关。EoE 中提供成本效益护理是一个研究不足的领域,以患者为中心的方法是关键。未来的研究可以在多个领域产生影响。这些包括确定治疗反应的预测因素、监测疾病活动的最小侵入性或非侵入性方法以及验证多学科护理的使用。

结论

嗜酸性粒细胞性食管炎(EoE)被认为是一种罕见疾病,但与 EoE 相关的护理成本和疾病负担是相当大的。然而,很少有研究探讨 EoE 的相关成本或 EoE 患者的成本效益护理方法。为了提供成本效益护理,以患者为中心的方法和共同决策模型是最佳选择。此外,还需要制定合理的 EoE 诊断和初始治疗策略、有效控制疾病的维持治疗,理想情况下可预防并发症,并进行适当的长期监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b63/6679981/235bcbb05b82/nihms-1527525-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b63/6679981/74298494b184/nihms-1527525-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b63/6679981/235bcbb05b82/nihms-1527525-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b63/6679981/74298494b184/nihms-1527525-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b63/6679981/235bcbb05b82/nihms-1527525-f0002.jpg

相似文献

1
Cost-effective care in eosinophilic esophagitis.嗜酸粒细胞性食管炎的成本效益护理。
Ann Allergy Asthma Immunol. 2019 Aug;123(2):166-172. doi: 10.1016/j.anai.2019.04.010. Epub 2019 Apr 19.
2
Cost-effectiveness model of endoscopic biopsy for eosinophilic esophagitis in patients with refractory GERD.内镜活检在难治性 GERD 患者中用于嗜酸性食管炎的成本效益模型。
Am J Gastroenterol. 2011 Aug;106(8):1439-45. doi: 10.1038/ajg.2011.94. Epub 2011 Mar 29.
3
Health-care utilization, costs, and the burden of disease related to eosinophilic esophagitis in the United States.美国嗜酸性粒细胞性食管炎的医疗保健利用、成本及疾病负担
Am J Gastroenterol. 2015 May;110(5):626-32. doi: 10.1038/ajg.2014.316. Epub 2014 Sep 30.
4
Health-Related Quality of Life and Costs Associated With Eosinophilic Esophagitis: A Systematic Review.健康相关生活质量与嗜酸性食管炎相关成本:系统评价。
Clin Gastroenterol Hepatol. 2018 Apr;16(4):495-503.e8. doi: 10.1016/j.cgh.2017.06.036. Epub 2017 Jun 24.
5
Promising Modalities to Identify and Monitor Eosinophilic Esophagitis.有前途的方法来识别和监测嗜酸性粒细胞性食管炎。
Clin Gastroenterol Hepatol. 2017 Nov;15(11):1655-1664. doi: 10.1016/j.cgh.2017.05.004. Epub 2017 May 10.
6
Cost of chronic inflammatory disease: The impact of eosinophilic esophagitis in Nevada.慢性炎症性疾病的成本:内华达州嗜酸性食管炎的影响。
J Dig Dis. 2020 Jan;21(1):12-19. doi: 10.1111/1751-2980.12832.
7
Economic Burden of Eosinophilic Esophagitis: A Nationwide Cost-of-Illness Study.嗜酸性粒细胞性食管炎的经济负担:一项全国疾病经济负担研究。
Am J Gastroenterol. 2024 Oct 1;119(10):2122-2125. doi: 10.14309/ajg.0000000000002868. Epub 2024 Mar 25.
8
Eosinophilic Esophagitis in Children.儿童嗜酸性粒细胞性食管炎
Curr Allergy Asthma Rep. 2017 Aug;17(8):54. doi: 10.1007/s11882-017-0721-2.
9
Model to Determine the Optimal Dietary Elimination Strategy for Treatment of Eosinophilic Esophagitis.用于确定嗜酸性粒细胞性食管炎治疗的最佳饮食排除策略的模型。
Clin Gastroenterol Hepatol. 2018 Nov;16(11):1730-1737.e2. doi: 10.1016/j.cgh.2018.04.013. Epub 2018 May 3.
10
Conservative long-term treatment of children with eosinophilic esophagitis.嗜酸细胞性食管炎患儿的保守长期治疗。
Ann Allergy Asthma Immunol. 2012 May;108(5):363-6. doi: 10.1016/j.anai.2012.02.024. Epub 2012 Mar 21.

引用本文的文献

1
Cost-utility analysis of sequential therapies for pediatric-onset eosinophilic esophagitis.儿童期嗜酸性粒细胞性食管炎序贯治疗的成本效用分析
J Pediatr Gastroenterol Nutr. 2025 Aug;81(2):295-303. doi: 10.1002/jpn3.70106. Epub 2025 Jun 9.
2
From Past to Present: The Evolution of Pharmacologic Therapies for Eosinophilic Esophagitis.从过去到现在:嗜酸性食管炎药物治疗的演变
Gastroenterol Hepatol (N Y). 2025 May;21(5):298-303.
3
Expert Opinion on the Management, Challenges, and Knowledge Gaps Pertaining to Eosinophilic Esophagitis Among Adults in the Greater Gulf Region.

本文引用的文献

1
Combination Therapy With Elimination Diet and Corticosteroids Is Effective for Adults With Eosinophilic Esophagitis.联合消除饮食和皮质类固醇治疗对嗜酸性粒细胞性食管炎成人有效。
Clin Gastroenterol Hepatol. 2019 Dec;17(13):2800-2802. doi: 10.1016/j.cgh.2019.03.009. Epub 2019 Mar 15.
2
Subcutaneous immunotherapy in patients with eosinophilic esophagitis.嗜酸性粒细胞性食管炎患者的皮下免疫疗法。
Ann Allergy Asthma Immunol. 2019 May;122(5):532-533.e3. doi: 10.1016/j.anai.2019.02.022. Epub 2019 Mar 2.
3
A Conceptual Approach to Understanding Treatment Response in Eosinophilic Esophagitis.
大湾地区成年人嗜酸性粒细胞性食管炎的管理、挑战及知识空白的专家意见
Clin Exp Gastroenterol. 2025 May 14;18:91-102. doi: 10.2147/CEG.S511469. eCollection 2025.
4
Yield of esophageal biopsy patterns for the diagnosis of eosinophilic esophagitis.用于诊断嗜酸性食管炎的食管活检模式的阳性率
Gastrointest Endosc. 2025 Aug;102(2):194-201.e1. doi: 10.1016/j.gie.2025.01.018. Epub 2025 Jan 18.
5
Patient experience with eosinophilic esophagitis symptoms and impacts on daily life based on in-trial qualitative interviews.基于试验中的定性访谈,患者对嗜酸性食管炎症状的体验及其对日常生活的影响。
J Patient Rep Outcomes. 2025 Jan 8;9(1):3. doi: 10.1186/s41687-025-00836-x.
6
Disease Burden and Spectrum of Symptoms that Impact Quality of Life in Pediatric Patients with Eosinophilic Esophagitis.嗜酸性粒细胞性食管炎患儿的疾病负担及影响生活质量的症状谱
Gastro Hep Adv. 2024 Aug 22;3(8):1054-1068. doi: 10.1016/j.gastha.2024.08.009. eCollection 2024.
7
Prevalence and Costs of Eosinophilic Esophagitis in the United States.美国嗜酸性粒细胞性食管炎的患病率及成本
Clin Gastroenterol Hepatol. 2025 Feb;23(2):272-280.e8. doi: 10.1016/j.cgh.2024.09.031. Epub 2024 Oct 31.
8
Cost-Effectiveness Analysis of Current Treatment Options for Eosinophilic Esophagitis.嗜酸性食管炎当前治疗方案的成本效益分析
Am J Gastroenterol. 2025 Jan 1;120(1):161-172. doi: 10.14309/ajg.0000000000003104. Epub 2024 Sep 30.
9
Advances in omics data for eosinophilic esophagitis: moving towards multi-omics analyses.在嗜酸性粒细胞性食管炎的组学数据方面的进展:迈向多组学分析。
J Gastroenterol. 2024 Nov;59(11):963-978. doi: 10.1007/s00535-024-02151-6. Epub 2024 Sep 19.
10
Extracellular matrix remodeling proteins as biomarkers for clinical assessment and treatment outcomes in eosinophilic esophagitis.细胞外基质重塑蛋白作为嗜酸性食管炎临床评估和治疗结果的生物标志物。
BMC Gastroenterol. 2023 Oct 16;23(1):357. doi: 10.1186/s12876-023-02977-z.
理解嗜酸性粒细胞性食管炎治疗反应的概念方法。
Clin Gastroenterol Hepatol. 2019 Oct;17(11):2149-2160. doi: 10.1016/j.cgh.2019.01.030. Epub 2019 Jan 30.
4
Transnasal Endoscopy in Unsedated Children With Eosinophilic Esophagitis Using Virtual Reality Video Goggles.经虚拟现实视频护目镜行无镇静下儿童嗜酸性食管炎经鼻内镜检查。
Clin Gastroenterol Hepatol. 2019 Nov;17(12):2455-2462. doi: 10.1016/j.cgh.2019.01.023. Epub 2019 Jan 29.
5
Consortium of Eosinophilic Gastrointestinal Disease Researchers: Advancing the Field of Eosinophilic GI Disorders Through Collaboration.嗜酸性胃肠道疾病研究人员联盟:通过合作推动嗜酸性胃肠道疾病领域的发展。
Gastroenterology. 2019 Mar;156(4):838-842. doi: 10.1053/j.gastro.2018.10.057. Epub 2018 Nov 17.
6
RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis.RPC4046,一种针对 IL13 的单克隆抗体,可降低嗜酸性食管炎患者的组织学和内镜活动。
Gastroenterology. 2019 Feb;156(3):592-603.e10. doi: 10.1053/j.gastro.2018.10.051. Epub 2018 Nov 2.
7
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018.美国胃肠道、肝脏和胰腺疾病的负担和成本:2018 年更新。
Gastroenterology. 2019 Jan;156(1):254-272.e11. doi: 10.1053/j.gastro.2018.08.063. Epub 2018 Oct 10.
8
Summary of the updated international consensus diagnostic criteria for eosinophilic esophagitis: AGREE conference.嗜酸性食管炎更新版国际共识诊断标准总结:AGREE会议
Ann Allergy Asthma Immunol. 2018 Sep;121(3):281-284. doi: 10.1016/j.anai.2018.05.035. Epub 2018 Jul 18.
9
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.更新的嗜酸性粒细胞性食管炎国际共识诊断标准:AGREE 会议纪要。
Gastroenterology. 2018 Oct;155(4):1022-1033.e10. doi: 10.1053/j.gastro.2018.07.009. Epub 2018 Sep 6.
10
Maintenance Treatment Of Eosinophilic Esophagitis With Swallowed Topical Steroids Alters Disease Course Over A 5-Year Follow-up Period In Adult Patients.口服局部类固醇维持治疗可改变成人患者在 5 年随访期间的嗜酸性食管炎的疾病进程。
Clin Gastroenterol Hepatol. 2019 Feb;17(3):419-428.e6. doi: 10.1016/j.cgh.2018.05.045. Epub 2018 Jun 11.